The frequency analyses revealed a significant higher proportion of SCA2 patients with P300 abnormalities, as well as a higher proportion of SCA2 preclinical carriers with prolonged P300 peak latencies (Fig. 2a). Here, ATXN2 is linked to spinocerebellar ataxia type 2.